drugset / Trial / NCT05304442

IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department

NCT05304442

RandomizedParallel-groupOpen-labelTreatment

Summary

The primary aim of this randomized trial is to assess the efficacy of IV Ferric Derisomaltose vs Oral Iron in the management of women with severe Iron Deficiency Anemia due to Uterine Bleeding in the emergency department.

Timeline

Start
2022-09-15
Primary completion
2025-03
Completion
2025-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferric Derisomaltose Unknown 1000 mg Intravenous
Comparator Ferrous Sulfate Diagnostic / imaging agent 65 mg Oral